Pulmonary Hypertension in Heart Failure: Effects of Heart Transplantation

  • R. Naeije
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine 1993 book series (YEARBOOK, volume 1993)

Abstract

Pulmonary hypertension secondary to chronic pulmonary venous hypertension in patients with congestive heart failure may become relatively fixed over time due to structural changes in the pulmonary vasculature [1]. An acute decrease in left atrial pressure (Pia) after cardiac transplantation in these patients may therefore be associated with high pulmonary arterial pressures (Ppa), persistent at levels known to be poorly tolerated by a normal right ventricle [2]. Accordingly, high preoperative pulmonary vascular resistance (PVR) has been found associated with a significant risk of fatal right ventricular (RV) failure after orthotopic cardiac transplantation [3–6]. In order to limit the frequency of this complication, patients with a PVR of more than 480 to 640 dynes.s.cm5 (6 to 8 Wood units) are generally excluded from the potential benefits of the surgical procedure [3–6]. Most recently, testing for a pharmacological reversal of elevated PVR at preoperative evaluation has been reported [6,7], and the results of these manipulations contended to be helpful for the prediction of postoperative pulmonary hemodynamics [6].

Keywords

Pulmonary Hypertension Right Ventricular Pulmonary Vascular Resi Cardiac Transplantation Left Atrial Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Grossman W, Braunwald E (1988) Pulmonary hypertension. In: Braunwald E (ed) Heart Disease. A textbook of cardiovascular medicine, 3rd ed. Philadelphia, WB Saunders Co pp 693–718Google Scholar
  2. 2.
    Guyton AC, Lindsey AW, Gilluly JJ (1954) The limits of right ventricular compensation following acute increase in pulmonary eireulatory resistance. Circ Res 2: 326–332PubMedGoogle Scholar
  3. 3.
    Griepp RB, Stinson EB, Doug E, Clark DA, Shumway NE (1971) Determinants of operative risk in human heart transplantation. Am J Surg 122: 192–197PubMedCrossRefGoogle Scholar
  4. 4.
    Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White–Williams C, Bourge RC (1988) Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7: 351–356Google Scholar
  5. 5.
    Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE (1991) Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 101: 432–445PubMedGoogle Scholar
  6. 6.
    Costard–Jäckle A, Fowler M (1992) Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coli Cardiol 19: 48–54CrossRefGoogle Scholar
  7. 7.
    Murali S, Uretsky BF, Reddy S, Tokarczyk TR, Betschart AR (1991) Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: Comparative effects of various pharmacologic agents. Am Heart J 122: 1375–1381PubMedCrossRefGoogle Scholar
  8. 8.
    Fishman AP (1985) Pulmonary circulation. In: Handbook of Physiology. The Respiratory System. Circulation and Nonrespiratory Function. Am Physiol Society, Bethesda, sect 3, vol I, chap 3, pp 92–166Google Scholar
  9. 9.
    Mitzner W, Chang HK (1989) Hemodynamics of the pulmonary circulation. In: Chang HK Paiva M (eds): Respiratory Physiology. An Analytieal Approach. Marcel Dekker, New York, pp 561–631Google Scholar
  10. 10.
    McGregor M, Sniderman A (1985) On pulmonary vascular resistance: The need for more precise definition. Am J Cardiol 55: 217–221PubMedCrossRefGoogle Scholar
  11. 11.
    Janicki JS, Weber KT, Likoff MJ, Fishman AP (1985) The pressure–flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 72: 1270–1278PubMedCrossRefGoogle Scholar
  12. 12.
    Naeije R, Lipski A, Abramowicz M, et al. (1993) Nature of pulmonary hypertension in congestive heart failure. Effects of cardiac transplantation. Am J Cardiol (in press)Google Scholar
  13. 13.
    Lejeune P, Naeije R, Leeman M, Melot C, Deloof T, Delcroix M (1987) Effects of dopamine and dobutamine on hyperoxic and hypoxic pulmonary vascular tone in dogs. Am Rev Respir Dis 136: 29–37PubMedCrossRefGoogle Scholar
  14. 14.
    Vincent JL, Carlier E, Pinsky MR, et al. (1992) Prostaglandin El infusion for right ventricular failure after cardiad transplantation. J Thorac Cardiovasc Surg 103: 33–39PubMedGoogle Scholar
  15. 15.
    Leeman M, Lejeune P, Closset J, Vachiery JL, Melet C, Naeije R (1990) Nature of pulmonary hypertension in canine oleic acid pulmonary edema. J Appl Physiol 69: 293–298PubMedGoogle Scholar
  16. 16.
    Bhatia SJS, Kirshenbaum JM, Shemin RJ, et al. (1987) Time course of resolution and right ventricular remodelling after orthotopic cardiac transplantation. Circulation 76: 819–826PubMedCrossRefGoogle Scholar
  17. 17.
    Villanueva FS, Murali S, Uretsky BF, et al. (1989) Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. J Am Coli Cardiol 14: 1239–1243CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • R. Naeije

There are no affiliations available

Personalised recommendations